CA Inc. (CA) to pay $0.26 on Sep 12, 2017; Bristol Myers Squibb Company (BMY) Shorts Lowered By 27.72%

August 21, 2017 - By wolcottdaily

CA Inc. (NASDAQ:CA) is expected to pay $0.26 on Sep 12, 2017. $1.02 is the ADY. (NASDAQ:CA) shareholders before Aug 22, 2017 will receive the $0.26 dividend. CA Inc.’s current price of $32.37 translates into 0.79% yield. CA Inc.’s dividend has Aug 24, 2017 as record date. Aug 10, 2017 is the announcement. The stock decreased 0.03% or $0.01 on August 18, reaching $32.37. About shares traded. CA, Inc. (NASDAQ:CA) has risen 0.22% since August 21, 2016 and is uptrending. It has underperformed by 16.48% the S&P500.

Bristol Myers Squibb Company (NYSE:BMY) had a decrease of 27.72% in short interest. BMY’s SI was 13.49M shares in August as released by FINRA. Its down 27.72% from 18.67M shares previously. With 8.74 million avg volume, 2 days are for Bristol Myers Squibb Company (NYSE:BMY)’s short sellers to cover BMY’s short positions. The stock decreased 0.69% or $0.39 on August 18, reaching $56.42. About shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since August 21, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

CA, Inc. is engaged in providing software solutions enabling clients to plan, develop, manage and secure applications and enterprise environments across distributed, cloud, mobile and mainframe platforms. The company has market cap of $13.64 billion. The Firm operates through three business divisions: Mainframe Solutions, Enterprise Solutions and Services. It has a 17.9 P/E ratio. The Company’s Mainframe Solutions and Enterprise Solutions divisions comprise the Company’s software business organized by the nature of its software offerings and the platform on which the products operate.

Since May 15, 2017, it had 0 buys, and 1 sale for $21,366 activity. On Monday, May 15 Sayed Ayman sold $21,366 worth of CA, Inc. (NASDAQ:CA) or 674 shares.

Investors sentiment decreased to 1.11 in 2016 Q4. Its down 0.22, from 1.33 in 2016Q3. It is negative, as 51 investors sold CA, Inc. shares while 155 reduced holdings. 48 funds opened positions while 180 raised stakes. 282.13 million shares or 1.33% more from 278.42 million shares in 2016Q3 were reported. Gulf Financial Bank (Uk) Ltd invested in 0.05% or 95,542 shares. 14,000 are owned by Meag Munich Ergo Kapitalanlagegesellschaft Mbh. Pinebridge Investments L P reported 0.01% in CA, Inc. (NASDAQ:CA). Price T Rowe Assoc Incorporated Md reported 2.38 million shares. Blackrock Japan Company Ltd, Japan-based fund reported 407,519 shares. The Israel-based Psagot Investment House has invested 0% in CA, Inc. (NASDAQ:CA). Manchester Cap Mgmt Limited Company holds 594 shares. Whittier Of Nevada Inc, Nevada-based fund reported 150 shares. Great West Life Assurance Company Can holds 0.03% of its portfolio in CA, Inc. (NASDAQ:CA) for 361,350 shares. Cantab Capital Partners Ltd Liability Partnership stated it has 64,046 shares or 0% of all its holdings. Teachers & Annuity Association Of America stated it has 259,400 shares. West Oak Cap Ltd Liability accumulated 0% or 2,103 shares. Comerica National Bank stated it has 0.19% of its portfolio in CA, Inc. (NASDAQ:CA). Ig Ltd, a Manitoba – Canada-based fund reported 340,788 shares. Ls Advsrs Ltd Liability Corporation holds 0.04% or 17,359 shares in its portfolio.

Among 15 analysts covering CA Technologies (NASDAQ:CA), 2 have Buy rating, 4 Sell and 9 Hold. Therefore 13% are positive. CA Technologies has $38 highest and $29 lowest target. $32.80’s average target is 1.33% above currents $32.37 stock price. CA Technologies had 25 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, January 22 by Mizuho. As per Friday, July 7, the company rating was maintained by Jefferies. Wells Fargo initiated the shares of CA in report on Wednesday, January 11 with “Underperform” rating. The stock of CA, Inc. (NASDAQ:CA) has “Neutral” rating given on Thursday, May 12 by Citigroup. The rating was downgraded by Barclays Capital to “Equal-Weight” on Friday, July 15. The stock of CA, Inc. (NASDAQ:CA) earned “Neutral” rating by Credit Suisse on Thursday, April 21. On Thursday, October 22 the stock rating was maintained by FBR Capital with “Mkt Perform”. Standpoint Research upgraded CA, Inc. (NASDAQ:CA) on Wednesday, November 18 to “Buy” rating. The rating was upgraded by Citigroup on Monday, November 16 to “Neutral”. TheStreet downgraded CA, Inc. (NASDAQ:CA) on Friday, October 23 to “Hold” rating.

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The company has market cap of $92.52 billion. The Company’s pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. It has a 20.56 P/E ratio. Small molecule drugs are administered orally in the form of a pill or tablet.

Since February 27, 2017, it had 1 buy, and 6 insider sales for $9.91 million activity. $681,240 worth of Bristol-Myers Squibb Co (NYSE:BMY) was bought by Samuels Theodore R. II. On Friday, March 17 Schmukler Louis S sold $282,470 worth of Bristol-Myers Squibb Co (NYSE:BMY) or 5,000 shares. ANDREOTTI LAMBERTO sold $1.81M worth of stock. 8,096 shares valued at $463,779 were sold by Caldarella Joseph C on Wednesday, March 15. LEUNG SANDRA sold $5.27M worth of stock or 92,405 shares.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It dived, as 86 investors sold Bristol-Myers Squibb Co shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Belgium-based Kbc Gru Nv has invested 0.19% in Bristol-Myers Squibb Co (NYSE:BMY). Amica Retiree Trust holds 9,944 shares. Aviance Prtnrs owns 16,396 shares or 0.34% of their US portfolio. Saratoga Inv owns 5,710 shares or 0.03% of their US portfolio. Usca Ria stated it has 40,709 shares or 0.37% of all its holdings. Becker Capital Management Inc reported 4,607 shares stake. Evergreen Cap Management Ltd Liability Corp holds 0.06% in Bristol-Myers Squibb Co (NYSE:BMY) or 5,533 shares. Patten Patten Tn has 129,711 shares. Blair William And Il holds 0.72% or 1.37M shares in its portfolio. Bailard Inc stated it has 21,740 shares. Redwood Investments Lc owns 19 shares. 15,142 were reported by West Chester. 9,649 are held by Finance Advisory Service Inc. The Florida-based Ariel Capital Advsrs Ltd Liability Corp has invested 0.13% in Bristol-Myers Squibb Co (NYSE:BMY). Ngam L P reported 311,831 shares stake.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. $62.38’s average target is 10.56% above currents $56.42 stock price. Bristol-Myers Squibb Company had 51 analyst reports since July 28, 2015 according to SRatingsIntel. Barclays Capital maintained Bristol-Myers Squibb Co (NYSE:BMY) on Friday, April 29 with “Equal Weight” rating. On Monday, January 25 the stock rating was downgraded by BMO Capital Markets to “Market Perform”. The firm has “Hold” rating given on Monday, August 14 by Cowen & Co. BMO Capital Markets maintained it with “Sell” rating and $4700 target in Monday, June 5 report. The rating was initiated by Hilliard Lyons on Monday, May 23 with “Neutral”. The firm has “Hold” rating given on Friday, October 28 by Deutsche Bank. As per Friday, August 19, the company rating was maintained by UBS. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Friday, August 5. As per Friday, September 9, the company rating was maintained by Barclays Capital. Berenberg upgraded the shares of BMY in report on Friday, January 22 to “Buy” rating.